Immune checkpoint blockade is associated with immune-related adverse events including pneumonitis, a severe potentially life threatening condition. Illustration shows inflammation to lung parenchyma with ground glass opacities showing on film and thickening of bronchioles. The background has a pattern of mAbs ipilimumab and nivolumab.